James Hoekstra to Platelet Aggregation Inhibitors
This is a "connection" page, showing publications James Hoekstra has written about Platelet Aggregation Inhibitors.
Connection Strength
1.869
-
Roe MT, Kikano G, Miller CD, Hoekstra JW. Continuum of care in the treatment of ST-segment elevation myocardial infarction (STEMI): importance of platelet and coagulation inhibition. Postgrad Med. 2008 Jul; 120(2):67-78.
Score: 0.304
-
Hoekstra JW. Managing antiplatelet therapy in the ACS patient: straight from the emergency department to you. J Hosp Med. 2008 Mar; 3 Suppl 2:S15-9.
Score: 0.297
-
Deitelzweig SB, Hoekstra JW. Peripheral arterial disease and the hospitalist: the rationale for early detection and optimal therapy. J Hosp Med. 2008 Mar; 3 Suppl 2:S4-8.
Score: 0.297
-
Hoekstra JW. Rules of engagement: the hospitalist and atherothrombosis. J Hosp Med. 2008 Mar; 3 Suppl 2:S1-3.
Score: 0.297
-
Geisler T, Droppa M, Gawaz M, Steinhubl SR, Bertrand ME, Lincoff AM, Cequier AR, Desmet W, Rasmussen LH, Hoekstra JW, Bernstein D, Deliargyris EN, Mehran R, Stone GW. Impact of anticoagulation regimen prior to revascularization in patients with non-ST-segment elevation acute coronary syndromes: The ACUITY trial. Catheter Cardiovasc Interv. 2016 Aug; 88(2):174-81.
Score: 0.125
-
Lefebvre CW, Hoekstra J. Approach to non-ST-segment elevation acute coronary syndrome in the emergency department: risk stratification and treatment strategies. Hosp Pract (1995). 2010 Apr; 38(2):40-9.
Score: 0.086
-
Fermann GJ, Raja AS, Peterson ED, Roe MT, Hoekstra JW, Milford-Beland S, Diercks DB, Pollack CV, Peacock WF, Summers R, Ohman EM, Gibler WB. Early treatment for non-ST-segment elevation acute coronary syndrome is associated with appropriate discharge care. Clin Cardiol. 2009 Sep; 32(9):519-25.
Score: 0.082
-
Lefebvre CW, Hoekstra JW, Bonaca M, Giugliano R. Glycoprotein IIb-IIIa inhibitors in the emergency department for patients with non-ST-elevation acute coronary syndromes: principles and practices. J Emerg Med. 2009 Feb; 36(2):162-70.
Score: 0.074
-
Boden WE, Hoekstra J, Miller CD. ST-elevation myocardial infarction: the role of adjunctive antiplatelet therapy. Am J Emerg Med. 2008 Feb; 26(2):212-20.
Score: 0.074
-
Miller CD, Banerjee A, Mahaffey KW, Kontos MC, Fermann G, Pollack CV, Antman E, Aylward P, Goodman SG, Santos R, Ferguson JJ, Califf RM, Hoekstra JW. Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial. Eur Heart J. 2007 May; 28(9):1079-84.
Score: 0.070
-
Tricoci P, Peterson ED, Chen AY, Newby LK, Harrington RA, Greenbaum AB, Cannon CP, Gibson CM, Hoekstra JW, Pollack CV, Ohman EM, Gibler WB, Roe MT. Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE). Am J Cardiol. 2007 May 15; 99(10):1389-93.
Score: 0.070
-
Roe MT, Christenson RH, Ohman EM, Bahr R, Fesmire FM, Storrow A, Mollod M, Peacock WF, Rosenblatt JA, Yang H, Fraulo ES, Hoekstra JW, Gibler WB. A randomized, placebo-controlled trial of early eptifibatide for non-ST-segment elevation acute coronary syndromes. Am Heart J. 2003 Dec; 146(6):993-8.
Score: 0.055
-
Cannon CP, Hoekstra JW, Larson DM, Mencia WA, Cornish J, Carter RD, Berry CA, Karcher RB. Individual quality improvement in acute coronary syndromes: a performance improvement initiative. Crit Pathw Cardiol. 2009 Mar; 8(1):43-8.
Score: 0.020
-
Cohen M, Hoekstra J, Giugliano R, Granger CB, Gurbel PA, Hollander JE, Manoukian SV, Pollack CV, Saucedo JF. Treatment strategies in non-ST-elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention: an evidence-based review of clinical trial results and treatment guidelines: report on a roundtable discussion. J Interv Cardiol. 2008 Aug; 21(4):283-99.
Score: 0.019